Literature DB >> 22840429

Non-alcoholic fatty liver disease and cardiovascular disease.

Raul D Santos1, Stefan Agewall.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22840429     DOI： 10.1016/j.atherosclerosis.2012.07.018

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  6 in total

1.  CD8+ T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease.

Authors:  Denitra A Breuer; Maria Cristina Pacheco; M Kay Washington; Stephanie A Montgomery; Alyssa H Hasty; Arion J Kennedy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-11-11       Impact factor: 4.052

Review 2.  Nonalcoholic fatty liver disease and cardiovascular disease.

Authors:  Hong Liu; Hong-Yun Lu
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

3.  Non-Alcoholic Fatty Liver Disease (NAFLD) in Obesity.

Authors:  Rushad Patell; Rupal Dosi; Harshal Joshi; Smit Sheth; Purav Shah; Sarfaraz Jasdanwala
Journal:  J Clin Diagn Res       Date:  2013-01-12

Review 4.  The Multifaceted Actions of Curcumin in Obesity.

Authors:  Vanessa Bianconi; Matteo Pirro; Seyed Mohammad Hassan Moallem; Muhammed Majeed; Paola Bronzo; Marco D'Abbondanza; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Silymarin in treatment of non-alcoholic steatohepatitis: A randomized clinical trial.

Authors:  Hassan Solhi; Ramin Ghahremani; Amir Mohammad Kazemifar; Zahra Hoseini Yazdi
Journal:  Caspian J Intern Med       Date:  2014

6.  Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study.

Authors:  Juanwen Zhang; Ying Zhao; Chengfu Xu; Yani Hong; Huanle Lu; Jianping Wu; Yu Chen
Journal:  Sci Rep       Date:  2014-07-25       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.